Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Semaglutide (Ozempic®) Use in Denmark 2018 Through 2023 ‒ User Trends and off-Label Prescribing for Weight Loss
Aurélie Mailhac, Lars C. Pedersen, Anton Pottegård, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 307-318
Open Access | Times Cited: 17

Showing 17 citing articles:

GLP-1 Receptor Agonist Use and Risk of Suicide Death
Peter Ueda, Jonas Söderling, Viktor Wintzell, et al.
JAMA Internal Medicine (2024)
Open Access | Times Cited: 20
Semaglutide: Nonarteritic Anterior Ischemic Optic Neuropathy in the FDA adverse event reporting system – A disproportionality analysis
Marina Azab, Luca Pasina
Obesity Research & Clinical Practice (2025)
Closed Access | Times Cited: 3
Use of semaglutide and risk of non‐arteritic anterior ischemic optic neuropathy: A Danish–Norwegian cohort study
Emma Simonsen, Lars Christian Lund, Martin Ernst, et al.
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 2
Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes
Jakob Grauslund, Andreas Abou Taha, Laleh Dehghani Molander, et al.
International Journal of Retina and Vitreous (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 16
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Gastrointestinal Cancers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Gisella Figlioli, Daniele Piovani, Spyros Peppas, et al.
Pharmacological Research (2024) Vol. 208, pp. 107401-107401
Open Access | Times Cited: 9
Survey among adult users of semaglutide for weight loss in Denmark: User characteristics, treatment expectations and experienced effects
Marc Sørensen, Anton Pottegård, Nanna Elman Andersen, et al.
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 1
Real‐world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP‐1RA‐based weight‐loss therapies
Reimar W. Thomsen, Aurélie Mailhac, Julie B. Løhde, et al.
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 1
Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish–Norwegian cohort study
Emma Simonsen, Lars Christian Lund, Martin Ernst, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
The Role of GLP‐1 Agonists in Esthetic Medicine: Exploring the Impact of Semaglutide on Body Contouring and Skin Health
Diala Haykal, Barbara Hersant, Hugues Cartier, et al.
Journal of Cosmetic Dermatology (2024)
Closed Access | Times Cited: 5
Trends in the use of drugs with weight‐loss effect: Scandinavian study from 2017 to 2023
Paz Lopez‐Doriga Ruiz, Lars Bakke Hindenes, Øystein Karlstad, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Prescribing patterns of glucagon-like peptide-1 receptor agonists in the Swedish capital region—a register-based cross-sectional study
Annica Fors, Tomas Forslund, Anders Sundström, et al.
European Journal of Clinical Pharmacology (2025)
Open Access
Consensus Statements on Managing Aesthetic Needs in Prescription Medication‐Driven Weight Loss Patients: An International, Multidisciplinary Delphi Study
Andreas Nikolis, Kaitlyn M. Enright, Sabrina G. Fabi, et al.
Journal of Cosmetic Dermatology (2025) Vol. 24, Iss. 4
Open Access
A Closer Look at the Dermatological Profile of GLP-1 Agonists
C PERSSON, Allison C Eaton, Harvey N. Mayrovitz
Diseases (2025) Vol. 13, Iss. 5, pp. 127-127
Open Access
Design and Biosynthesis of Ornithine 8-Containing Semaglutide Variants with a Click Chemistry-Modifiable Position 26
Yanli Xu, Oscar P. Kuipers
ACS Synthetic Biology (2025)
Closed Access
Commentary on “Facial Remodeling Addressing Fat Loss and Skin Sagging With Poly-l-Lactic Acid SCA and Hyaluronic Acid Filler After Semaglutide-Associated Prescriptive Weight Loss”
Hélio Amante Miot
Dermatologic Surgery (2025)
Closed Access
Influence of BMI-associated genetic variants and metabolic risk factors on weight loss with semaglutide: a longitudinal clinico-genomic cohort study
Matthew E. Levy, Natalie Telis, Kelly M. Schiabor Barrett, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Development and Exploitation of RiPPs technology for Peptide Engineering
Yanli Xu
(2024)
Closed Access
Page 1

Scroll to top